Case Report
Copyright ©The Author(s) 2020.
World J Hepatol. Mar 27, 2020; 12(3): 108-115
Published online Mar 27, 2020. doi: 10.4254/wjh.v12.i3.108
Table 2 Reports of patients with intrahepatic sickle cell cholestasis who underwent liver transplantation
Ref.YearNumber of casesAge of the patientOutcomes
Emre et al[15]200016First transplant was complicated by graft failure from veno-occlusive disease, required re-LT.
Second transplant was complicated by graft failure from hepatic artery thrombosis, required re-LT.
The patient died 6 mo after third LT from sepsis.
Ross et al[18]2002149The patient died 22 mo after LT due to pulmonary embolism.
Gilli et al[19]2002122The patient was alive 3 mo after LT.
Baichi et al[7]2005127Post-LT course was complicated by sepsis, multiorgan failure, perihepatic hematoma and hemorrhagic ascites; the patient died 35 d after LT.
Mekeel et al[9]200728,17Patients were followed up over a mean period of 4.2 yr.
Patient 1 was alive at end of follow-up with mild recurrent HCV.
Patient 2 had recurrent sickle cell hepatopathy post-transplant and died of cerebral complications 6 yr following LT.
Hurtova et al[6]2011532-47Patient 1 died of recurrent HCV-induced decompensated cirrhosis and sepsis 11 yr after LT.
Patient 2 had recurrent HCV with moderate fibrosis; died of ischemic cholangitis and sepsis after 4 yr after LT.
Patient 3 had recurrent HCV infection. He was alive 8 yr after LT.
Patient 4's post-operative course was complicated by posterior leukoencephalopathy; the patient died from sepsis 16 mo after LT.
Patient 5 developed biliary strictures requiring stenting. The patient was alive 42 mo after LT.
Blinder et al[20]2013137Immediate post-LT course was complicated with seizure and respiratory failure. The patient had no post-operative SCD-related complications in the 12 mo after transplant and was maintained on hydroxyurea without need for exchange transfusion.
Lui et al[3]2018129The patient was alive 7 mo after LT with no reported complications.